Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Fresh Tracks Therapeutics Inc V.BBI


Primary Symbol: FRTX

Fresh Tracks Therapeutics, Inc. is not engaged in any business activities. The Company is in the process of dissolution.


PINL:FRTX - Post by User

Comment by Ditto99on Jul 20, 2017 12:23pm
292 Views
Post# 26491001

RE:RE:RE:RE:RE:RE:RE:New person

RE:RE:RE:RE:RE:RE:RE:New personNope, never worked for BBI nor would I, just know the assets/industry well. The reason I'm ''hard'' on them is that I hate to see unsuspecting retail investors fooled, call it a chip on my shoulder from other flash in the pan type investments I've seen friends and family make only to be left with a capital loss. 

If I could give any advice on listening to "Street Consensus" is to consider their motives, which leads me back to incestuous relationships. Comack and Haywood Co-led the $85 million equity raise, of which they get a 4.5% cut. They are essentially paid to pump the stock, that's why they list these outrageous "targets". Like it or not, this is how industry works. It's in Comacks best interest to pump this name so their included in the next equity raise (diluting shareholders BTW), securing another 4.5% clip. You want to talk about incestuous relationships, really dig into price targets of boutique brokerage firms like Haywook, Comark, Perters, GMP, etc, etc, etc. There is a direct correlation between higher "targets" and who led the last issuance. 

Another good example is Leucrotta. Take a look at Haywoods target on LXE. The CEO of LXE's son works at Haywood as a IBanker. Think about that....
Bullboard Posts